Why the study?
Does ex vivo 31P MRS of heart grafts provide metabolic markers that predict early graft failure?
Population
26 heart grafts harvested in the vicinity of the transplantation centre over a 3-year period
Design
Cohort
Follow-up
early post-transplant (weaning from CPB)
Authors
Loading...
Ex vivo 31P MRS markers were associated with graft outcomes; hypothesis-generating and should not yet change practice.
Does ex vivo 31P MRS of heart grafts provide metabolic markers that predict early graft failure?
Ex vivo 31P MRS of heart grafts provides metabolic markers that significantly correlate with early graft failure after transplantation.
Caus et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: